Page last updated: 2024-08-22

camptothecin and rocaglaol

camptothecin has been researched along with rocaglaol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aubert, G; Baguet, A; Bernard, Y; Cresteil, T; Désaubry, L; Dirr, R; Nebigil, CG; Sonenberg, N; Svitkin, Y; Thuaud, F; Tomasetto, C; Türkeri, G	1

Other Studies

1 other study(ies) available for camptothecin and rocaglaol

Article	Year
Synthetic analogue of rocaglaol displays a potent and selective cytotoxicity in cancer cells: involvement of apoptosis inducing factor and caspase-12. Journal of medicinal chemistry, 2009, Aug-27, Volume: 52, Issue:16 Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; Apoptosis Inducing Factor; Benzofurans; Caspase 12; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Endoplasmic Reticulum; G2 Phase; Humans; Stereoisomerism; Structure-Activity Relationship	2009

Article

Year

Synthetic analogue of rocaglaol displays a potent and selective cytotoxicity in cancer cells: involvement of apoptosis inducing factor and caspase-12.

Journal of medicinal chemistry, 2009, Aug-27, Volume: 52, Issue:16

Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; Apoptosis Inducing Factor; Benzofurans; Caspase 12; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Endoplasmic Reticulum; G2 Phase; Humans; Stereoisomerism; Structure-Activity Relationship

2009